Avian Influenza Vaccine Market By Vaccine Type (Inactivated Vaccines, live recombinant vaccines, Combination vaccines, Others), By Application (Chicken, Duck, Turkey, Goose, Others), By Strain (H5, H7, H9), By Route of Administration (Intranasal, Intramuscular, Others), and By Distribution Channel (Online, Offline {Veterinary Clinics, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Nov 2024 | Report ID: MI1388 | 220 Pages


Report Coverage:

By Vaccine Type

  • Inactivated Vaccines
  • live recombinant vaccines
  • Combination vaccines
  • Others

By Application

  • Chicken
  • Duck
  • Turkey
  • Goose
  • Others

By Strain

  • H5
  • H7
  • H9

By Route of Administration

  • Intranasal
  • Intramuscular
  • Others

By Distribution Channel

  • Online
  • Offline
    • Veterinary Clinics
    • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • HIPRA
  • Bayer AG
  • Phibro Animal Health
  • Zoetis
  • Ceva Santé Animale
  • Merck & Co., Inc.
  • Vetoquinol
  • Elanco Animal Health
  • Zoetis Inc.
  • Boehringer Ingelheim GmbH
  • Virbac
  • Elanco
  • Bioniche Animal Health
  • Indian Immunological
  • Hester Biosciences Ltd.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.